Literature DB >> 9690795

Cross-reactivity and heterologous neutralization of crotaline antivenoms used in Argentina.

A R de Roodt1, J A Dolab, T Fernández, L Segre, S E Hajos.   

Abstract

The immunochemical cross-reactivity and neutralizing capacity of four crotalinae antivenoms consisting in equine F(ab')2 fragments and available in Argentina (bothropic Bivalent, against Bothrops alternatus and B. neuwiedii venoms; bothropic Tetravalent, against B. alternatus, B. neuwiedii; B. jararaca and B. jararacussu venoms; bothropic crotalic Trivalent, against B. alternatus, B. neuwiedii and Crotalus (C.) durissus terrificus venoms and anticrotalic against C. d. terrificus venom) were studied against B. alternatus, B. ammodytoides; B. jararaca; B. jararacussu, B. moojeni; B. neuwiedii and C. d. terrificus venoms. SDS-PAGE analysis of the Bothrops venoms showed protein bands of high (>40 kDa) medium (20-40 kDa) and low (<15 kDa) molecular weights, while that of C. d. terrificus exhibited a large amount of material with molecular weight of 15.0 kDa or lower. Immunoblotting showed a high cross-reactivity of all the major protein bands with all the antivenoms (even heterologous) tested. All the antivenoms were effective in neutralizing the lethal activity of the venoms tested, and in some cases (B. jararaca and B. jararacussu) heterologous antivenoms exhibited similar neutralizing capacity than the homologous ones. In spite of the differences in biochemical composition and pharmacology, Bothropic antivenoms displayed a significant neutralizing capacity on lethal activity of C. d. terrificus venom. In addition, all the antivenoms (including the anticrotalic) were highly effective in neutralizing the hemorragic, necrotizing, procoagulant, and proteolytic activities. The antivenoms tested produced different degrees of inhibition of phospholipase A2 activity, which exhibited a certain specificity but was also related to the enzyme content in the venom.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690795     DOI: 10.1016/s0041-0101(97)00111-6

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

Review 1.  New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India.

Authors:  David A Warrell; José Maria Gutiérrez; Juan J Calvete; David Williams
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

2.  Alkylation of histidine residues of Bothrops jararacussu venom proteins and isolated phospholipases A2: a biotechnological tool to improve the production of antibodies.

Authors:  C L S Guimarães; S H Andrião-Escarso; L S Moreira-Dill; B M A Carvalho; D P Marchi-Salvador; N A Santos-Filho; C A H Fernandes; M R M Fontes; J R Giglio; B Barraviera; J P Zuliani; C F C Fernandes; L A Calderón; R G Stábeli; F Albericio; S L da Silva; A M Soares
Journal:  Biomed Res Int       Date:  2014-05-11       Impact factor: 3.411

3.  Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping.

Authors:  Mikael Engmark; Bruno Lomonte; José María Gutiérrez; Andreas H Laustsen; Federico De Masi; Mikael R Andersen; Ole Lund
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

Review 4.  Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead.

Authors:  José María Gutiérrez; Gabriela Solano; Davinia Pla; María Herrera; Álvaro Segura; Mariángela Vargas; Mauren Villalta; Andrés Sánchez; Libia Sanz; Bruno Lomonte; Guillermo León; Juan J Calvete
Journal:  Toxins (Basel)       Date:  2017-05-13       Impact factor: 4.546

5.  Fast venomic analysis of Crotalus durissus terrificus from northeastern Argentina.

Authors:  Luciano S Fusco; Emidio B Neto; Aleff F Francisco; Jorge Alfonso; Andreimar Soares; Daniel C Pimenta; Laura C Leiva
Journal:  Toxicon X       Date:  2020-06-15

Review 6.  Global Availability of Antivenoms: The Relevance of Public Manufacturing Laboratories.

Authors:  José María Gutiérrez
Journal:  Toxins (Basel)       Date:  2018-12-24       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.